Fostamatinib
RxNorm 2044896
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2044896 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fostamatinib.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Fostamatinib
(Atom ID: 10270860)
PTPrescribable
Designated preferred name (PT):
Fostamatinib
(Atom ID: 10803346)
FNPrescribable
Full form of descriptor (FN):
Fostamatinib (substance)
(Atom ID: 10803347)
PTPrescribable
Designated preferred name (PT):
Fostamatinib-containing product
(Atom ID: 10803350)
FNPrescribable
Full form of descriptor (FN):
Product containing fostamatinib (medicinal product)
(Atom ID: 10811113)
Patient Education
Fostamatinib
Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment. Fostamatinib is in a class of medications called kinase inhibitors. It works by reducing platelet destruction.
[Learn More]
* Please review the disclaimer below.